This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07307/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07307/identifier/pubchem-compound/
n10http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB07307/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07307/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07307/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07307
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB07307 n12:DB07307
dcterms:title
N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide
adms:identifier
n4:99443778 n7:DB07307 n8:A17 n13:23343202 n14:24941253
n5:IUPAC-Name
n6:271B5E87-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5E8D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5E8C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5E89-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5E8A-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5E8B-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5E85-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5E83-363D-11E5-9242-09173F13E4C5 n6:271B5E86-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5E84-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5E93-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5E94-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5E8E-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5E8F-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5E91-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5E90-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5E92-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5E99-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5E9B-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5E9C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5E98-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5E97-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5E9A-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5E88-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5E95-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5E96-363D-11E5-9242-09173F13E4C5